SCHEMBL2349339

SCHEMBL2349339

CCCCC(CC)C(C)(C)[O]

nearest known ligand 0.43

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CA2 P00918 8/20 0.43
MAPK1 P28482 1/20 0.43
CA1 P00915 4/20 0.41
FDPS P14324 2/20 0.41
TSHR P16473 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 3/20 0.36
TDP1 Q9NUW8 1/20 0.36
DNM1 Q05193 2/20 0.35
CYP3A4 P08684 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2348663 0.91 FDPS (0.47) CA2FDPSTSHRDNM1
SCHEMBL2344705 0.90 FDPS (0.43) CA2MAPK1CA1FDPSTSHR
SCHEMBL2349556 0.85 FDPS (0.41) CA2MAPK1CA1FDPSTSHR
SCHEMBL2344768 0.85 FDPS (0.50) CA2MAPK1CA1FDPSDNM1
SCHEMBL2347173 0.83 FDPS (0.53) CA2FDPSTSHRDNM1
SCHEMBL2345749 0.83 FDPS (0.53) CA2FDPSTSHRDNM1
SCHEMBL2348673 0.83 FDPS (0.53) CA2FDPSTSHRDNM1
SCHEMBL11496837 0.81 CA2 (0.42) CA2MAPK1CA1FDPSTSHR
SCHEMBL2351491 0.80 FDPS (0.50) CA2FDPSTSHRDNM1
SCHEMBL2352745 0.80 FDPS (0.50) CA2FDPSTSHRDNM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078724-B1 PROCESS FOR PRODUCTION OF DIALKYLTIN DIALKOXIDES ASAHI CHEMICAL IND (JP) 2016-11-30 EP disclosed
CN-104151162-A Process for production of alkyl tin alkoxide compound, and process for production of carbonate ester using the compound ASAHI KASEI CHEMICALS CORP 2014-11-19 CN disclosed
CN-101522697-B Process for production of dialkyltin dialkoxides ASAHI KASEI CHEMICALS CORP (JP) 2013-05-29 CN disclosed
EP-2226328-B1 PROCESS FOR PRODUCTION OF ALKYL TIN ALKOXIDE COMPOUND, AND PROCESS FOR PRODUCTION OF CARBONATE ESTER USING THE COMPOUND ASAHI KASEI CHEMICALS CORP (JP) 2012-12-26 EP disclosed
US-8168812-B2 Process for producing alkyl tin alkoxide compound and process for producing carbonic acid ester using said compound ASAHI KASEI CHEMICALS CORPORATION (JP) 2012-05-01 US disclosed
US-8008518-B2 Process for producing dialkyl tin dialkoxides ASAHI KASEI CHEMICALS CORPORATION (JP) 2011-08-30 US disclosed
CN-102112482-A Method for producing alkyl tin alkoxide compound and method for producing carbonate ester using the same ASAHI CHEMICAL CORP 2011-06-29 CN disclosed
US-20100292496-A1 Process for Production of Alkyl Tin Alkoxide Compound, and Process for Production of Carbonic Acid Ester Using the Compound ASAHI KASEI KABUSHIKI KAISHA (JP) 2010-11-18 US disclosed
EP-2226328-A1 PROCESS FOR PRODUCTION OF ALKYL TIN ALKOXIDE COMPOUND, AND PROCESS FOR PRODUCTION OF CARBONATE ESTER USING THE COMPOUND Asahi Kasei Chemicals Corporation (JP) 2010-09-08 EP disclosed
US-20100041908-A1 PROCESS FOR PRODUCING DIALKYL TIN DIALKOXIDES ASAHI KASEI KABUSHIKI KAISHA (JP) 2010-02-18 US disclosed
EP-2078724-A1 PROCESS FOR PRODUCTION OF DIALKYLTIN DIALKOXIDES Asahi Kasei Chemicals Corporation (JP) 2009-07-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041908-A1 PROCESS FOR PRODUCING DIALKYL TIN DIALKOXIDES DEK, DDT, DERA CA2 1514/4885MAPK1 4077/4885CA1 1354/4885
US-20100292496-A1 Process for Production of Alkyl Tin Alkoxide Compound, and Process for Production of Carbonic Acid Ester Using the Compound OXSR1, AOC2, OXER1 CA2 924/4885MAPK1 404/4885CA1 2082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.